Regulation (EU) 2017/745, known as the MDR – Medical Device Regulation, is the European regulation governing the manufacture, distribution, and monitoring of medical devices.
Fully applicable since May 26, 2021, the regulation has replaced the previous European directives issued in the 1990s, introducing new standards of safety, quality, and traceability for all operators involved in the medical device supply chain.
The MDR Regulation sets out the rules that manufacturers, distributors, and industry operators must follow to place compliant medical devices on the European market.
Unlike the previous directives, the regulation is directly binding in all Member States without the need for national transposition, and it aims to:
The MDR applies to all medical devices and to devices with a non-strictly medical purpose that present similar risks to health.
The regulation involves four main categories of economic operators:

Places MDR-compliant devices on the market under its own name or trademark

Represents non-EU manufacturers and ensures their compliance

Places compliant devices on the European market

Makes devices available up to the point of use.
All these parties now share direct responsibilities for the safety and monitoring of the device throughout its entire lifecycle.
The regulation establishes stricter rules than in the past.
Among the main obligations:
These measures strengthen trust in the European market, protect patients, and improve the overall quality of medical devices.
UDI (Unique Device Identification)
EUDAMED (European Database on Medical Devices)
PRRC (Person Responsible for Regulatory Compliance)
Each manufacturer must appoint a qualified person, either internal or external, responsible for ensuring ongoing compliance with the MDR and the proper management of technical documentation, CE conformity, and post-market surveillance.
PMS (Post Market Surveillance)
The post-market surveillance system enables the collection and analysis of data on device performance once it has been placed on the market. PMS is essential for the early identification of potential risks and for continuously improving the safety of medical devices.
Dr. Protec adopts a rigorous approach to ensure full compliance with Regulation (EU) 2017/745, providing safe, certified, and reliable devices:
The MDR Regulation represents a crucial turning point for the medical device sector, placing greater emphasis on safety, accountability, and traceability.
Dr. Protec is committed to meeting and exceeding these standards on a daily basis, offering certified and compliant products that ensure reliability and protection for professionals and patients.
Registered Office
Via Porlezza, 8
20123 Milan (MI) Italy
Operational Headquarters
Via dell’Artigianato, 26
36057 Torri di Arcugnano (VI) Italy
Head Office
Via Brescia, 31 c/o Vicenza Business Tower
36040 Torri di Quartesolo (VI) Italy
Copyright © 2026 | Bericah S.p.A. – VAT No. and Tax Code: 00899910244 – Milan Companies Register No. 00899910244 – Share Capital €120,000.00 fully paid up